C7R-GD2.CAR T Cells

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for C7R-GD2.CAR T Cells, covering 2025-09-04 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma [Phase 1]

See pricing